Novo Nordisk Plans Lower-Price Ozempic to Fight Generics
Pharmaceutical giant Novo Nordisk is considering a strategic rebrand of a lower-price version of Ozempic to compete directly with upcoming generic alternatives. Learn about the potential market shift.